Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Findings of 18 F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample.
Bun S, Moriguchi S, Tezuka T, Sato Y, Takahata K, Seki M, Nakajima S, Yamamoto Y, Sano Y, Suzuki N, Morimoto A, Ueda R, Tabuchi H, Ito D, Mimura M. Bun S, et al. Among authors: tezuka t. Neuropsychopharmacol Rep. 2022 Dec;42(4):437-448. doi: 10.1002/npr2.12281. Epub 2022 Jul 17. Neuropsychopharmacol Rep. 2022. PMID: 35843629 Free PMC article.
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.
Shimohama S, Tezuka T, Takahata K, Bun S, Tabuchi H, Seki M, Momota Y, Suzuki N, Morimoto A, Iwabuchi Y, Kubota M, Yamamoto Y, Sano Y, Shikimoto R, Funaki K, Mimura Y, Nishimoto Y, Ueda R, Jinzaki M, Nakahara J, Mimura M, Ito D. Shimohama S, et al. Among authors: tezuka t. Neurology. 2023 Jan 17;100(3):e264-e274. doi: 10.1212/WNL.0000000000201389. Epub 2022 Sep 29. Neurology. 2023. PMID: 36175151
Can the clinical sign "head-turning sign" and simple questions in "Neucop-Q" predict amyloid β pathology?
Daté Y, Bun S, Takahata K, Kubota M, Momota Y, Iwabuchi Y, Tezuka T, Tabuchi H, Seki M, Yamamoto Y, Shikimoto R, Mimura Y, Hoshino T, Kurose S, Shimohama S, Suzuki N, Morimoto A, Oosumi A, Hoshino Y, Jinzaki M, Mimura M, Ito D. Daté Y, et al. Among authors: tezuka t. Alzheimers Res Ther. 2024 Nov 21;16(1):250. doi: 10.1186/s13195-024-01605-6. Alzheimers Res Ther. 2024. PMID: 39568089 Free PMC article.
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status.
Bun S, Ito D, Tezuka T, Kubota M, Ueda R, Takahata K, Moriguchi S, Kurose S, Momota Y, Suzuki N, Morimoto A, Hoshino Y, Seki M, Mimura Y, Shikimoto R, Yamamoto Y, Hoshino T, Sato Y, Tabuchi H, Mimura M. Bun S, et al. Among authors: tezuka t. Alzheimers Res Ther. 2023 Sep 4;15(1):149. doi: 10.1186/s13195-023-01296-5. Alzheimers Res Ther. 2023. PMID: 37667408 Free PMC article.
Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report.
Nukariya T, Tezuka T, Okusa S, Okochi R, Sakai Y, Nihei Y, Nakahara J, Seki M. Nukariya T, et al. Among authors: tezuka t. J Mov Disord. 2025 Jan 6. doi: 10.14802/jmd.24247. Online ahead of print. J Mov Disord. 2025. PMID: 39757596 Free article. No abstract available.
Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report.
Tezuka T, Nukariya T, Kizuka Y, Okusa S, Okochi R, Sakai Y, Nihei Y, Nakahara J, Seki M. Tezuka T, et al. J Mov Disord. 2024 Oct;17(4):453-455. doi: 10.14802/jmd.24114. Epub 2024 Jun 28. J Mov Disord. 2024. PMID: 38945151 Free PMC article. No abstract available.
561 results